BOSTON, Nov. 3 /PRNewswire-FirstCall/ -- Albert Liou, Corporate Vice President and General Manager, Asia-Pacific Region, at PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services provider, will present "What Can China Really Deliver in Terms of Cost and Efficiency Savings in Running Clinical Trials?" at the 7th Annual Partnerships in Clinical Trials Congress and Exhibition, to be held November 4 - 7, 2008 at the Estrel Convention Center in Berlin, Germany. PAREXEL is a sponsor of the congress.
During PAREXEL's presentation, taking place on Wednesday, November 5 at 3:25 p.m. CET, Mr. Liou will explore various issues and considerations for conducting clinical research in China, including approaches to identify well-established investigator sites, the extent of improvements in quality and innovation, strategies for overcoming regulatory hurdles, and ways to ensure compliance with U.S. Food and Drug Administration (FDA), European Medicines Agency (EMEA), and GxP standards.
With 13 locations throughout the Asia-Pacific region, including offices in Beijing, Hong Kong, and Shanghai, China, PAREXEL has had a long-term commitment to providing a high level of standardization and quality clinical development services in these geographies. PAREXEL helps clients address key challenges in conducting studies in the Asia-Pacific region and globally, including accessing diverse patient populations, navigating regulatory issues, identifying investigators, and ensuring data quality.
For over 25 years, PAREXEL has been a proven and committed partner to
pharmaceutical, biotechnology, and medical device companies looking to
bring innovative new products to market. PAREXEL has extensive experience
|SOURCE PAREXEL International Corporation|
Copyright©2008 PR Newswire.
All rights reserved